Glucose versus lactate in immature brain slices

Related Q&A: Y Ben-Ari writes that ‘Zilberter and Bregestovski and colleagues’ dealt with ‘ketone body metabolites’. What does ketone body metabolite mean? ”

About this post

1. These quotes were first used by Elly Strammer at F1000.com. After she agreed to remove her post from there, she contacted us suggesting that we use the quotes. We thank Elly for her contribution and for further commenting at the Naturally Selected

2. We received many questions regarding this post, quite a few of them concerned the formatting, which was not helping to clearly understand the issue. Because of that, we updated the post making sure to visually indicate quotes belonging to the arguing sides (according to F1000.comNow, remarks related to comments concerning the works of Y. Zilberter et al. are marked as  and remarks by Y. Ben-Ari are marked as 

 ”We demonstrate that in the neonatal brain, Em [membrane potential] and EGABA [reversal potential of GABA-induced anionic currents] strongly depend on composition of the energy substrate pool. Complementing glucose with ketone bodies, pyruvate or lactate resulted in a significant hyperpolarization of both Em and EGABA, and induced a radical shift in the mode of GABAergic synaptic transmission towards network inhibition.” (1)

“The main conclusions of our work are that the inhibitory effect of L-lactate on GDPs is not mediated by mitochondrial energy metabolism, and that glucose at its standard 10 mM concentration is an adequate energy substrate for neonatal neurons in vitro.” (2)

 ”We show that in the presence of glucose, lactate is effectively utilized as an energy substrate, causing an augmentation of oxidative metabolism. Moreover, in the absence of glucose lactate is fully capable of maintaining synaptic function. Therefore, during network activity in neonatal slices, lactate can be an efficient energy substrate capable of sustaining and enhancing aerobic energy metabolism.” (3)

“Lactate is not an efficient replacement for glucose and, as in vivo glucose is always kept at 4-5mM in the brain even in conditions of severe stress.” (4 a)

“The fact is, in the extracellular fluid (ECF) in the brain, glucose concentration is between 1.9 mM and 0.59 while lactate concentration is between 5.1 mM and 0.78 mM (for review, see [9 in this post]). The question arises: why 10 mM glucose in standard ACSF is adequate but 10 mM lactate is not.” (5)

“Clearly, the suggestions of Zilberter and colleagues rely on wrong assumptions and results that have not been reproduced.” (4 a)

“The effect of weak acids on GABA reversal potential and GDP generation was initially described for 4-5 mM concentrations of BHB [ketone body beta-hydroxybutyrate] (Rheims et al. 2009 ), lactate and pyruvate (Holmgren et al. 2010), and was later confirmed by independent research groups for similar concentrations of pyruvate (Tyzio et al. 2011), lactate and propionate (Ruusuvuori et al. 2010).” (6)

“From a clinical perspective, it is interesting to stress that relying on their observations on the positive actions of lactate on metabolism, Zilberter and colleagues have suggested that administration of lactate may be “a novel therapeutic tool to cure Parkinson, Alzheimer, Leigh syndrome and epilepsies” (4a)

 From Brain Fuels: This quotation is taken out of context. The exact piece from (9) reads: “… a growing body of evidence shows that metabolic stress caused by impaired energy homeostasis is a common feature of neurodegenerative disorders (NDDs) such as Alzheimer disease, Leigh syndrome, epilepsy, dementia, multiple sclerosis, neuropathies or ataxias [88] and [89]. We speculate that endogenous ES such as lactate, BHB and pyruvate or their combinations can be efficient in treatingNDD, and would address the cause rather than symptoms. Indeed, the neuroprotective effects of pyruvate have been repeatedly demonstrated in cases of brain ischemia, hypoglycemia, hemorragia, stroke and kainate-inducedepileptic brain damage[90], [91], [92]and [93]. Further research into mechanisms of the effects of ES on fundamental neuronal properties might allow more rapid progress in preventing and managing NDDs.

The comment made on 29 Jul 2011 (4 b) quoted this paragraph with the references removed thus attributing the text solely to (9).

“Considering the compelling and well-known clinical observation that high lactate level is a classical sign of neuron suffering and severe conditions that require rapid intervention, this suggestion is, to say the least, astonishing.” (4 a)

“The bulk of the evidence suggests that lactate is an important intermediary in numerous metabolic processes, a particularly mobile fuel for aerobic metabolism, and perhaps a mediator of redox state among various compartments both within and between cells. Lactate can no longer be considered the usual suspect for metabolic ‘crimes’, but is instead a central player in cellular, regional and whole body metabolism… we might term the period from the 1930s to approximately the early 1970s the dead-end waste product era.” (7)

” It is curious that Dr Zilberter and colleagues refer to metabolism but have never reported measuring it.” (4 b)

“…Ivanov et al. (2011) simultaneously recorded oxygen tension, NAD(P)H fluorescence transients and local field potentials during electrical stimulation of the hippocampal Schaffer collateral pathway in neonatal brain tissue slices from mice. From the very beginning, the authors took great care to ensure both viability and functionality of their preparations. They convincingly demonstrated that surprisingly high superfusion rates with standard artificial cerebrospinal fluid (ACSF) in the slice chamber are required to ensure adequate oxygenation and complete electrical function in blood-free tissue slices. An important implication of this methodological tour de force is that under many previously reported experiments the requirements for viability may been met while the functionality may have been compromised.” (8)

References

  1. Holmgren, C. D., Mukhtarov, M., Malkov, A. E., Popova, I. Y., Bregestovski, P., and Zilberter, Y. (2010). Energy substrate availability as a determinant of neuronal resting potential, GABA signaling and spontaneous network activity in the neonatal cortex in vitro. J. Neurochem. 112, 900–912.
  2. Ruusuvuori E et al. (2010). Spontaneous network events driven by depolarizing GABA action in neonatal hippocampal slices are not attributable to deficient mitochondrial energy metabolism. J Neurosci. Nov 17; 30(46):15638-42
  3. Ivanov A, Mukhtarov M, Bregestovski P and Zilberter Y (2011) Lactate effectively covers energy demands during neuronal network activity in neonatal hippocampal slices. Front. Neuroenerg. 3:2.
  4. Ben-Ari Y.  a) Faculty of 1000, 06 Jan 2011, evaluation,  b) 29 Jul 2011, comment.
  5. Zilberter Y. Faculty of 1000, 19 May 2011 and July 14 2011, comments.
  6. Khakhalin A (May 18, 2011). Questioning the depolarizing effects of GABA during early brain development. J Neurophysiol doi: 0.1152/jn.00293.2011.
  7. Mendel I. Faculty of 1000, 04 Jun 2011, comment (Currently the comment is removed).
  8. Kasischke K (2011) Lactate fuels the neonatal brain. Front. Neuroenerg. 3:4. doi: 10.3389/fnene.2011.00004
  9. Zilberter Y, Zilberter T, Bregestovski P. (2010) Neuronal activity in vitro and the in vivo reality: the role of energy homeostasis. Trends PharmacolSci 31:394–401.

Sweet and sour recipes for the brain 4. “Physiological” concentrations: what and where?

What concentrations are physiological and what are not (usually called pharmacological)? The physiological ones  normally refer to the levels of a substance relevant to the naturally occurring, which, logically, for neurons is the milieu they strive in. It is called extracellular fluid (ECF) and is notorious for dramatic differences with not only blood (plasma) but even with the cerebrospinal fluid (CSF).

“Importantly, microdialysis data have shown that both in adult humans and in rats,the basal glucose levels are about 1–2 mM in the ECF of the neocortex and hippocampus [32,33,37,38] compared with 5–7 mM in the blood, whereas concentrations of lactate are about 2–5 mM in the ECF [32,34,39,40] compared with 1–2 mM in the adult blood.” (Zilberter et al., 2010). The authors further stressed the imperative of providing adequate means for energy substrates to be utilized in the artificial milieu, in which brain slices are placed:

“In brain slices, energy deficiency cannot be managed in the same way as in whole-body homeostasis, resulting in higher ES levels in  slices than in vivo. The importance of a proper oxygen supply should be stressed [55], because oxidative phosphorylation is proportional to the presence of O2. Therefore, at an inadequate oxygen level, the efficacy of ES might be negligible. It is not surprising that energy metabolism in slices differs from that occurring in the living brain, and is probably impaired [52–54].”

Khakhalin (2011) wrote in his recent review that effects of ES on GABA action has been shown for “…4-5  mM concentrations of beta-hydroxybutyrate  (Rheims et al. 2009), lactate and pyruvate (Holmgren et al. 2010), and was later confirmed by independent research groups for similar concentrations of pyruvate (Tyzio et al. 2011), and lactate (Ruusuvuori et al. 2010).” He continued arguing whether  the concentrations were  ”physiological ” in the experiments showing equal results in different authors who made, however, different conclusions: Tyzio et al. state that the physiological concentration of pyruvate is 1.6 – the one they measured in plasma.

“This comparison may be not valid, however, as it is well known from microdialysis studies that the extracellular fluid, immediately surrounding neural cells, differs in its composition not only from the blood plasma, but even from the cerebrospinal fluid. In particular, concentration of lactate in the extracellular fluid of rats and humans was found to be 2-5 times higher than in the blood plasma… 4-5 mM concentrations are likely to be physiologically relevant… On the other hand, at these concentrations both lactate and pyruvate induce noticeable changes in GABA- and glutamatergic transmission in developing neural networks. It means that some changes in experimental protocols and related theoretical paradigms may still be necessary.”

Kasischke (2011) in his comment on the article by Ivanov et al., 2011, wrote: “From the very beginning, the authors took great care to ensure both viability and functionality of their preparations.”

“An important implication of this methodological tour de force is that under many previously reported experiments the requirements for viability may been met while the functionality may have been compromised.”

References

 

  1. Zilberter Y, Zilberter T, Bregestovski P. (2010) Neuronal activity in vitro and the in vivo reality: the role of energy homeostasis. Trends Pharmacol Sci., 31(9):394-401
  2. [32,33,3437,38,39,40,52-55]  are cited in Zilberter et al. (2010)
  3. Khakhalin A (May 18, 2011). Questioning the depolarizing effects of GABA during early brain development. J Neurophysiol doi: 0.1152/jn.00293.2011.
  4. Tyzio et al. (2011) and  Ruusuvuori et al. (2010) are cited in Khakhalin ( 2011).
  5. Kasischke K (2011). Lactate fuels the neonatal brain. Frontiers in Neuroenergetics; 3, 4

“Brain metabolism in vitro” and those sour energy substrates

This paper suggests that the developmental switch in the reversal potential for gamma-aminobutyric acid (GABA) is regulated by different energy sources

This paper suggests that the developmental switch in the reversal potential for gamma-aminobutyric acid (GABA) is regulated by different energy sources

An evaluation of our article (1) appeared in the “Faculty of 1000 postpublication peer reviews” the conclusion being:

The findings of Rheims et al. have a potentially major impact on our understanding of GABAergic function during development, bringing back an element of inhibition in developing neuronal networks that appeared to rely entirely on excitatory connections (2).

This article (1) along with the article (3) later became an indirect subject of another evaluation (4) although formally, the evaluation concerned a different paper (5), which has been commended because (the author’s words):

“It settles an important issue related to brain metabolism in vitro and the role of acidification in brain patterns.”

The acidification issue doesn’t seem to be resolved either in 5 nor in 4, so a comment to the evaluation appeared in May 2011,  stating among other things the following:

We showed that inhibition of spontaneous network activity in neonatal hippocampal slices by energy substrates is not correlated with intracellular acidification (7) and that they work altering intrinsic features of energy metabolism namely NAD(P)H and oxygen utilization (8).

Another data challenged in 5 is whether lactate as efficient as an energy substrate: “Lactate is not an efficient replacement for glucose” wrote Dr Ben-Ari and Y. Zilberter in his comment referred to the paper 8 titled “Lactate effectively covers energy demands during neuronal network activity in neonatal hippocampal slices” and the work of Wyss et al. (9) titled “In Vivo Evidence for Lactate as a Neuronal Energy Source”.

References

1. Rheims S, Holmgren CD, Chazal G, Mulder J, Harkany T, Zilberter T, Zilberter Y. (2009) J Neurochem.  Aug;110(4):1330-8. Epub 2009 Jun 22. (on Brain Fuels)

2. Scimemi A, Diamond J: 2009. F1000.com/1166168

3. Holmgren CD, Mukhtarov M, Malkov AE, Popova IY, Bregestovski P, Zilberter Y. (2010) J Neurochem. Feb;112(4):900-12. Epub 2009 Nov 24. (on Brain Fuels)

4. Ben-Ari Y: 2011. F1000.com/6913961

5. Ruusuvuori E, Kirilkin I, Pandya N, Kaila K (2010) J Neurosci.  Nov 17; 30(46):15638-42

6. Zilberter Y, Zilberter T, Bregestovski P. (2010) Trends Pharmacol Sci., 31(9):394-401 (on Brain Fuels)

7. Mukhtarov, M., Ivanov, A., Zilberter, Y., and Bregestovski, P. (2011) J Neurochem 116, 316-321

8. Ivanov A, Mukhtarov M, Bregestovski P and Zilberter Y (2011) Front. Neuroenerg. 3:2.

9. Wyss M, Jolivet R, Buck A, Magistretti P, and Weber B. (2011)  J Neuroscience, 31(20):7477-7485

Excitatory GABA: “Maybe It’s Not So Exciting After All!”

The Epilepsy Currents journal, Volume 10, Issue 5, pages 128–130, September/October 2010, published an article titled “Another Look at Early GABAergic Neurotransmission: Maybe It’s Not So Exciting After All!” by Jong M. Rho MD.

Pros and Cons of reconsidering the excitatory GABA dogma according to Dr Rho, in direct quotes *

PROs:

  • “Collectively, these studies cast doubt on the biological relevance of GABA-induced depolarization as evidenced by a multitude of cellular electrophysiological studies.” [1, 2]
  • “Certainly, these authors make a compelling case for a thoughtful re-examination of the time-honored use of ACSF formulations that solely employ glucose as an energy substrate.” **
  • “If the observations of Rheims et al. and Holmgren and colleagues are ultimately validated, then a couple of generations of in vitro studies are likely to be at risk for relegation to the murky domain of artifact.”
CONs

  • “Intriguing as their findings are, the authors have not yet firmly established a mechanism for their general observation ofmetabolic substrate-induced reversal of GABA excitation, despite preliminary evidence invoking the bicarbonate–chloride exchanger.”
  • “Although Rheims et al. and Holmgren and colleagues indicate that their results may be similar to the mechanism of ketogenic action, this link remains speculative at best.”
  • “Whether GABA-evoked depolarization is merely a developmental aberration that is compensated for by differential and age-dependent utilization of energy substrates or whether it is still a fundamental physiological phenomenon important for neuronal maturation, and possibly seizure genesis, remains unclear.” ***

————–

*  all six points are direct quotations of Dr Rho selected to demonstrate his opinion of the papers (1, 2)

** see recent review: Neuronal activity in vitro and the in vivo reality: the role of energy homeostasis

*** There’s a growing body of evidence in favor  the first part of the statement and against its second part showing that the excitatory GABA phenomenon exists only in certain conditions: either brain slices supported by standard ACSF or, if in vivo, during blockade of ketogenesis (3). In healthy immature animals in vivo (3, 4) , as well as in hippocampal preparations in toto (5-7), GABA is shown to always be inhibitory.

References

1. GABA Action in Immature Neocortical Neurons Directly Depends on the Availability of Ketone Bodies. Rheims S, Holmgren CD, Chazal G,Mulder J, Harkany T, Zilberter T, Zilberter Y. J Neurochem 2009;110(4):1330–1338

2. Energy Substrate Availability as a Determinant of Neuronal Resting Potential, GABA Signaling and Spontaneous Network Activity in the Neonatal Cortex In Vitro. Holmgren CD,MukhtarovM,Malkov AE, Popova IY, Bregestovski P, Zilberter Y. J Neurochem 2010;112(4):900–912

3. Rheims S., PhD thesis, Universite de la Mediterranee, 2008

4.  Bremner L, Fitzgerald M & Baccei M. (2006). Functional GABAA-Receptor-Mediated Inhibition in the Neonatal Dorsal Horn. J Neurophysiol 95, 3893-3897

5. Wong, T., et al. (2005) Postnatal development of intrinsic GABAergic rhythms in mouse hippocampus. Neuroscience 134, 107-120

6. Derchansky, M., et al. (2008) Transition to seizures in the isolated immature mouse hippocampus: a switch from dominant phasic inhibition to dominant phasic excitation. J Physiol 586, 477-494

7. Dzhala V et. al., Progressive NKCC1-Dependent Neuronal Chloride Accumulation during Neonatal Seizures The Journal of Neuroscience, (2010) 30(35):11745–11761 • 11745

Great Controversies in Neurobiogy

They teach us in our institutes that GABA is excitatory in the neonates, should we still believe it?” (Excitatory GABA scandal?)

There was an interesting development in the Department of Neuroscience of the Brown University who published a provocative recommendation to the Neuro 193E Course under the general title “Great Controversies in Neurobiogy.”

Since 80′s it was becoming a firmly established fact that in immature brain, the reversal potential for GABA receptors was more depolarized, making GABA excitatory and producing a special form of electrical activity named the giant depolarizing potentials, GDP, described by Ben-Ari in hippocampal slices of the immature brain.

“This is something which has been widely described in multiple brain regions by many different labs and is pretty much accepted as fact,” wrote the course’s authors. “However,” continues the chapter, “about a year ago, a couple of papers from the Zilberter’s lab (1, 2) have seriously brought this fact into question.”

The matter is, as multiple prior studies showed [as reviewed in 3, BF], the immature brain “is not very good at metabolizing glucose” due to the immaturity of glycolytic mechanisms and instead it relies on brain fuels alternative to glucose, such as ketones, lactate, and/or pyruvate.

“They noted that almost all papers published using brain slices use artificial cerebro-spinal fluid (ACSF) made with pleny of glucose, but no ketones. Which means that any immature slices cut and maintained in this media will likely be metabolically compromised.”

“They show quite convincingly that adding ketone bodies to ACSF used for immature slices actually makes GABA reversal potential more negative, similar to an adult neuron. Thus they suggest that the depolarizing actin of GABA during early development is an experimental artifact of metabolically-compromised brain slices,” concluded the author.

Source: Dept. of Neuroscience, Brown University. Course Neuro 193E. Last edited by Carlos Aizenman-Stern on Aug 24, 2010 15:34

References

  1. GABA Action in Immature Neocortical Neurons Directly Depends on the Availability of Ketone Bodies. Rheims S, Holmgren CD, Chazal G,Mulder J, Harkany T, Zilberter T, Zilberter Y. J Neurochem 2009;110(4):1330–13382.
  2. Energy Substrate Availability as a Determinant of Neuronal Resting Potential, GABA Signaling and Spontaneous Network Activity in the Neonatal Cortex In Vitro. Holmgren CD,MukhtarovM,Malkov AE, Popova IY, Bregestovski P, Zilberter Y. J Neurochem 2010;112(4):900–912
  3. Neuronal activity in vitro and the in vivo reality: the role of energy homeostasis. Trends Pharmacol Sci. 2010 Sep;31(9):394-401. Epub 2010 Jul 14. Zilberter Y, Zilberter T, Bregestovski P.

How does GABA behave in the intact brain?

Original Q&A :: About these Q&A :: Other Q&A

Q: Dr. Zilberter,

In your post at brainfuels.com, you cited several researchers and the closing phrase was: “The work undermined the role of depolarizing GABA”, commented Dr. Jean-Marc Goaillard from the Mediterranean University in Marseille”.

First, does depolarizing equals inhibitory? Second, I just wondered:  why nobody directly measured GABA properties in the whole brain, in natural conditions? Wouldn’t it be the final proof of how GABA behaves in its natural environment?

Thank you,

Theo

A: Dear Theo,

I believe you mean the post On the theory of excitatory GABA, correct me if I am wrong.

Depolarization of neuronal membrane is a change making it more electrically positive, or less negative. In neurons it may result in an action potential if the depolarization is larger than certain threshold. If this event repeats on a regular basis, the neuron or a network of connected neurons becomes more active (more frequently generating action potentials). In the case of GABA, the primary inhibitory neurotransmitter, depolarization means that it is in a less inhibitory state often failing to prevent the excitatory transmitter(s) from hyperactivity, which in clinical sense can mean seizures.

Hyper-polarization, on the other hand, inhibits the occurrence of an action potential, in his respect, when GABA is inhibitory, the odds of hyperactivity decrease. Now, regarding your second (excellent!) question, I can give you a reference to a PhD thesis, where the student reported this exact result (1). He investigated GABA properties in  whole mice (in vivo) and demonstrated that GABA was always inhibitory – unlike experimental results obtained on brain slices where GABA was depolarizing in young animals. Since in this project, researchers (the student, S. Rheims and his supervisor, Dr. Y. Zilberter) were interested in ketone bodies as the usual suspect when it comes to the anti-epileptic effects of the ketogenic diet, they chemically blocked the ketogenesis preventing ketone bodies from being produced to work as brain fuel.


In this condition, GABA behaved pretty much as it does in brain slices. This and the in toto (see footnote) experiment results, tell us that the “excitatory GABA” is, perhaps: 1) result of experimental limitation of the brain slice preparation; 2) GABA action depend on metabolic status of not only brain slice but also of a whole intact animal in a bad metabolic condition.

Footnote. Since this Q&A, I posted results on in toto experiments (2, 3, 4), where GABA was also inhibitory in the preparation of a whole hippocampus of immature animals : Studies of GABA action: in vivo, in toto, and in vitro and in vivo experiments showing inhibitory GABA-action (5).

Sources:

1. S. Rheims; PhD Thesis,2008. Faculté des Sciences de Luminy Ecole Doctorale de la Vie et de la Santé. Initiation et modulation des oscillations physiologiques et pathologiques dans le neocortex immature: role de la transmission GABAergique.

2. Wong, T., et al. (2005) Postnatal development of intrinsic
GABAergic rhythms in mouse hippocampus. Neuroscience 134, 107-120

3. Derchansky, M., et al. (2008) Transition to seizures in the
isolated immature mouse hippocampus: a switch from dominant phasic
inhibition to dominant phasic excitation. J Physiol 586, 477-494

4. Dzhala V et. al., Progressive NKCC1-Dependent Neuronal Chloride Accumulation during Neonatal Seizures The Journal of Neuroscience, (2010) 30(35):11745–11761 • 11745

5. Bremner L, Fitzgerald M & Baccei M. (2006). Functional GABAA-Receptor-Mediated Inhibition in the Neonatal Dorsal Horn. J Neurophysiol 95, 3893-3897.

Neuronal activity in vitro and the in vivo reality

In the brain, neuronal electrical activity and intricate metabolic energy provisions are closely related. Although both functions have been painstakingly researched by electrophysiologists and biochemists, insufficient interaction between the two domains leads to difficulty in extrapolating the properties observed in the in vitro studies to the properties of the whole in vivo brain. In this paper, we hope to clarify the relationships between neuronal energy status and neuronal electrical function.

“A man with his head is something much more then a man’s body plus his separate head” – J. Miller (1965)

Whole is equal to more than the sum of its parts (on some interdisciplinary methodological problems)

In the history of life sciences, perhaps beginning with Aristotle’s time, reductionism prevailed leaving the opposite philosophical approach, holism, outside scientific paradigm. Reductionism and reductionists are concerned with at least two dominant themes: a) the interactions between different domains of knowledge; b) the place of a part in the whole (1). (more…)

Studies of GABA action: in vivo, in toto, and in vitro

On discrepancies of data from experiments on brain slices, in toto, and in vivo

Let's start with the fundamental differences between environments depending on the types of experiments.

(See Commentary: Excitatory GABA: “Maybe It’s Not So Exciting After All!”)

neuroscience, brain energy homeostasis, set point, control system, in vivo, in vitro

Brain energy homeostasis versus energy supply in the brain slice preparation.

A. Energy homeostasis of the brain serves to meet brain’s energy needs in spite of environmental and metabolic disturbances. It continuously compares the correlates of energy requirements (SET POINT) with the actual energy supply (OUTPUT) through the negative feedback loop sending information about OUTPUT to the brain metabolic sensors. When the difference between SET POINT and OUTPUT exceeds certain value, a correction signal is sent to the control centers responsible for the initiation of the executive systems. The goal of executive system is fixing the consequences of disturbances. As the result, within the homeostatic margins, the required and actual energy supplies are maintained close to each other.

B. Brain slice is lacking all mandatory elements of a homeostatic system receiving instead a constant and arbitrary energy supply, which is independent of both qualitative and quantitative needs of cells.

C. When brain structures are preserved as in the in toto preparation  (not shown on the figure), there’s the possibility that energy substrates can come from the glial depots (1, 2)

As an example, let’s consider these four situations with GABA action:

1. In vitro (brain slice) using standard ACSF (footnote a)

GABA is consistently reported to be excitatory in the neonatal brain slices (e.g., 3 for review)

2. In vitro (neonatal’s brain slice) using energy substrate-fortified ACSF

GABA is inhibitory  (4, 5)

3. In toto, hippocampus (footnote b) preparation

In the intact neonatal hippocampus preparation, standard ACSF, intensive oxygenation (!), GABA is inhibitory (6, 7, 8 )

4. In vivo (neonates)

GABA is inhibitory in the normal neonates (9, 10,11) but it is much less inhibitory during chemical blockade of ketone’s production (blockade of ketogenesis) (9).

Sources

Sources:
1.
The astrocyte–neuron ketone body shuttle
http://brainfuels.com/category/theories/astrocyte–neuron-ketone-shuttle/
2.
The astrocyte–neuron lactate shuttle
http://brainfuels.com/category/theories/astrocyte–neuron-lactate-shuttle/
3.
Ben-Ari, Y., et al. (2007) GABA: a pioneer transmitter that excites
immature
neurons and generates primitive oscillations. Physiol Rev 87, 1215-
1284
4.
Rheims, S., et al. (2009) GABA action in immature neocortical neurons
directly
depends on the availability of ketone bodies. J Neurochem 110, 1330-
1338
5.
Holmgren CD, et. al., (2010) Energy substrate availability as a
determinant of neuronal resting potential, GABA signaling and
spontaneous network activity in the neonatal cortex in vitro. J
Neurochem. Feb;112(4):900-12. Epub 2009 Nov 24.
6.
Wong, T., et al. (2005) Postnatal development of intrinsic GABAergic
rhythms
in mouse hippocampus. Neuroscience 134, 107-120
7.
Derchansky, M., et al. (2008) Transition to seizures in the isolated
immature
mouse hippocampus: a switch from dominant phasic inhibition to
dominant
phasic excitation. J Physiol 586, 477-494
8.
S. RHEIMS. THESE DE DOCTORAT. Pour obtenir le grade de DOCTEUR DE
L’UNIVERSITE AIX MARSEILLE II. Spécialité : neurosciences. Le 31
octobre 2008

1. The astrocyte–neuron ketone body shuttle

2. The astrocyte–neuron lactate shuttle

3. Ben-Ari, Y., et al. (2007) GABA: a pioneer transmitter that
excites immature neurons and generates primitive oscillations. Physiol
Rev 87, 1215-1284

4. Rheims, S., et al. (2009) GABA action in immature neocortical
neurons directly depends on the availability of ketone bodies. J
Neurochem 110, 1330-1338

5. Holmgren CD, et. al., (2010) Energy substrate availability as a
determinant of neuronal resting potential, GABA signaling and
spontaneous network activity in the neonatal cortex in vitro. J
Neurochem. Feb;112(4):900-12. Epub 2009 Nov 24.

6. Wong, T., et al. (2005) Postnatal development of intrinsic
GABAergic rhythms in mouse hippocampus. Neuroscience 134, 107-120

7. Derchansky, M., et al. (2008) Transition to seizures in the
isolated immature mouse hippocampus: a switch from dominant phasic
inhibition to dominant phasic excitation. J Physiol 586, 477-494

8. Dzhala V et. al., Progressive NKCC1-Dependent Neuronal Chloride Accumulation during Neonatal Seizures The Journal of Neuroscience, (2010) 30(35):11745–11761 • 11745

9. Rheims S., PhD thesis, Universite de la Mediterranee, 2008

10. Bremner L, Fitzgerald M & Baccei M. (2006). Functional GABAA-Receptor-Mediated Inhibition in the Neonatal Dorsal Horn. J Neurophysiol 95, 3893-389

Footnotes

a) ACSF – artificial cerebrospinal fluid (CSF). This solution closely matches the electrolyte concentrations of CSF – A Harvard Bioscience Company

b) Hippocampus – a complex neural structure shaped like a sea horse, has a central role in the formation of memories


On the theory of excitatory GABA

As described in the post “On the mechanisms of brain protection by ketones“, GABA, the principal brain chemical, normally  acts to prevent hyperactivity in the neuronal networks. However, in the immature neurons, it acts to promote hyperactivity, at least this is how a twenty-year theory goes. This phenomenon is used to explain many properties of the developing brain (1). The “excitatory GABA” or “depolarizing GABA” (which are not the same, but it can become rather technical to explain) results were obtained in the in vitro experiments when a very thin slice of the brain survives in an artificial solution (ACSF) — the same solution for for both mature and immature brains. (more…)

Not only ketone bodies: on neuroprotective effects of energy substrates

In the previous post On the mechanisms of brain protection by ketones, I described how a shortage of ketones caused pathological changes in brain cells in brain slices (in vitro, 1) and in whole animals (in vivo, 2) resulting in abnormal (excitatory) behavior of GABA, the principal brain chemical helping to resist hyperactivity. (more…)

Older Posts » To leave a comment or question click here